Novo Nordisk
NVO
NVO
1,510 hedge funds and large institutions have $22.9B invested in Novo Nordisk in 2025 Q1 according to their latest regulatory filings, with 143 funds opening new positions, 619 increasing their positions, 548 reducing their positions, and 247 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $30.1B → $22.9B (-$7.21B)
26% less call options, than puts
Call options by funds: $987M | Put options by funds: $1.34B
42% less first-time investments, than exits
New positions opened: 143 | Existing positions closed: 247
Holders
1,510
Holding in Top 10
24
Calls
$987M
Puts
$1.34B
Top Buyers
| 1 | +$266M | |
| 2 | +$191M | |
| 3 | +$163M | |
| 4 |
Amundi
Paris,
France
|
+$109M |
| 5 |
Two Sigma Investments
New York
|
+$90.5M |
Top Sellers
| 1 | -$894M | |
| 2 | -$375M | |
| 3 | -$294M | |
| 4 |
Renaissance Technologies
New York
|
-$104M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$79.3M |
